Research roundup

Debbie Rigby presents her weekly round-up of the latest clinical research relevant to community pharmacy Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder This study represents the first evaluation of the relative benefits of onabotulinumtoxinA compared with mirabegron in adults with idiopathic overactive bladder. An indirect comparison indicates that onabotulinumtoxinA may be superior to